Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.38 USD | -5.06% | -3.43% | -31.99% |
May. 15 | PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 10 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
Evolution of the average Target Price on PDS Biotechnology Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering PDS Biotechnology Corporation
B. Riley | |
Oppenheimer | |
HC Wainwright | |
Chardan Research | |
Alliance Global Partners | |
Cantor Fitzgerald | |
Chardan |
EPS Revisions
- Stock Market
- Equities
- PDSB Stock
- Consensus PDS Biotechnology Corporation